nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-3786Research ArticleШКОЛА НЕФРОЛОГАEDUCATIONAL MATERIALSОсновные принципы диетотерапии больных хронической почечной недостаточностью, получающих лечение постоянным амбулаторным перитонеальным диализомMain Principles Of Diet Of Patients With Chronic Renal Failure On Continuous Ambulatory Peritoneal DialysisШадурС. С.ShadurS. .noemail@neicon.ruВольпянЛ. Л.VolpianL. .noemail@neicon.ruБакстер Экспорт КорпорейшнRussian Federation20002806202521-26269Copyright © Шадур С.С., Вольпян Л.Л., 20252025Шадур С.С., Вольпян Л.Л.Shadur S..., Volpian L...Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/3786

Мировая практика лечения постоянным амбулаторным перитонеальным диализом (ПАПД) больных хронической почечной недостаточностью (ХПН) неоспоримо доказывает огромное значение питания как фактора успешного лечения и реабилитации этих больных.

терминальная ХПНлечение ПАПДбелково-энергетическая недостаточностьдиетотерапиякомпоненты диетыReferencesСалтанов А.И., Обухова О. А., Кадырова Э.Г. Оценка питательного статуса в анестезиологии и интенсивной терапии //Вестник интенсивной терапии, 1996, №4, 42-48.Салтанов А.И., Обухова О. А., Кадырова Э.Г. Оценка питательного статуса в анестезиологии и интенсивной терапии //Вестник интенсивной терапии, 1996, №4, 42-48.Смирнов А.В. Уремическая дислипопротеидемия. Нефрология, 1998; т.2; 2: 15-24.Смирнов А.В. Уремическая дислипопротеидемия. Нефрология, 1998; т.2; 2: 15-24.Смирнов А.В., Козлов В.В. Клинические проявления атеросклероза у больных на гемодиализе. Нефрология, 1998; т.2; 2: 68-77.Смирнов А.В., Козлов В.В. Клинические проявления атеросклероза у больных на гемодиализе. Нефрология, 1998; т.2; 2: 68-77.Смирнов А.В. Лечение нефротической и уремической дислипопротеидемий. Нефрология, 1998; т.2; 3: 22-30.Смирнов А.В. Лечение нефротической и уремической дислипопротеидемий. Нефрология, 1998; т.2; 3: 22-30.Acchiardo S.R., Kraus A.P., Kaufman P.A. et al: Serum albumin a marker for morbidity and mortality in CAPD patients. J Am Soc Nephrol 1993; 4: 396.Acchiardo S.R., Kraus A.P., Kaufman P.A. et al: Serum albumin a marker for morbidity and mortality in CAPD patients. J Am Soc Nephrol 1993; 4: 396.Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; Vol.39; 169-183.Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; Vol.39; 169-183.Asayama К., Ito H., Nokahara C.H. et al. Lipid profiles and li-pase activities in children and adolescents with chronic renal failure treated conservatively or with Hemodialysis or transplantation Pediat. Res. 1984; Vol.18; 8: 783-788.Asayama К., Ito H., Nokahara C.H. et al. Lipid profiles and li-pase activities in children and adolescents with chronic renal failure treated conservatively or with Hemodialysis or transplantation Pediat. Res. 1984; Vol.18; 8: 783-788.Attman P.O. Hyperlipoproteinemia in renal failure: pathogenesis and perspectives for intervention. Nephrol. Dial. Transplant. 1993; Vol. 8; 294-295.Attman P.O. Hyperlipoproteinemia in renal failure: pathogenesis and perspectives for intervention. Nephrol. Dial. Transplant. 1993; Vol. 8; 294-295.Attman P.O., Alaupovic P., Tavella M., Knight-Gibson C. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol. Dial. Transplant. 1996; Vol. 11; 1: 63-69.Attman P.O., Alaupovic P., Tavella M., Knight-Gibson C. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol. Dial. Transplant. 1996; Vol. 11; 1: 63-69.Attman P.O., Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteidemia - relation to renal function and dialysis. Nephron. 1991; Vol.57; 401-410.Attman P.O., Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteidemia - relation to renal function and dialysis. Nephron. 1991; Vol.57; 401-410.Auguet Т., Senty M., Rubies-Prat J. et al. Serum lipoprotein/a/ concentration in patient with chronic renal failure receiving haemodialysis: influence of apolipoprotein/a/ genetic polymorphism. Nephrol. Dial. Transplant. 1993; Vol.8; 10: 1099-1103.Auguet Т., Senty M., Rubies-Prat J. et al. Serum lipoprotein/a/ concentration in patient with chronic renal failure receiving haemodialysis: influence of apolipoprotein/a/ genetic polymorphism. Nephrol. Dial. Transplant. 1993; Vol.8; 10: 1099-1103.Avram M.M., Golwasser P., Burrel D.E. et al. The uremic dislipidemia: a cross-sectional and longitudial study. Amer. J. Kidney Dis. 1992; Vol.20; 4: 324-335.Avram M.M., Golwasser P., Burrel D.E. et al. The uremic dislipidemia: a cross-sectional and longitudial study. Amer. J. Kidney Dis. 1992; Vol.20; 4: 324-335.Avram M.M., Golwasser P., Erroa M. et al. Predictors of survival in conti nuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am. J. Kidney Dis. 1994; 23: 91-98.Avram M.M., Golwasser P., Erroa M. et al. Predictors of survival in conti nuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am. J. Kidney Dis. 1994; 23: 91-98.Bannister D.К., Acchiardo S.R., Moore L.W., Kraus A.P. Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis /CAPD/ patients. J. Am. Diet. Ass. 1987; 87: 53-56.Bannister D.К., Acchiardo S.R., Moore L.W., Kraus A.P. Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis /CAPD/ patients. J. Am. Diet. Ass. 1987; 87: 53-56.Bergstrom J., Furst P., Alvestrand A., Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney lnt.1993; 44; 1048-1057.Bergstrom J., Furst P., Alvestrand A., Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney lnt.1993; 44; 1048-1057.Blumberg A., Hanck A., Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis/CAPD/. Clin. Nephrol. 1983; 20: 244-250.Blumberg A., Hanck A., Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis/CAPD/. Clin. Nephrol. 1983; 20: 244-250.Blumenkrantz M.J., Gahl G.M., Kopple J.D. et al. Protein losses during peritoneal dialysis. Kidney Int. 1981; 19: 593-602.Blumenkrantz M.J., Gahl G.M., Kopple J.D. et al. Protein losses during peritoneal dialysis. Kidney Int. 1981; 19: 593-602.Blumenkrantz M.J. Nutritional aspects of peritoneal dialysis. - In: Diamond L, Benis J., Deane N. et al. - Proceedings of the Renal Physicians Association: Northeastern Meating, NY. 1979; 3: 29.Blumenkrantz M.J. Nutritional aspects of peritoneal dialysis. - In: Diamond L, Benis J., Deane N. et al. - Proceedings of the Renal Physicians Association: Northeastern Meating, NY. 1979; 3: 29.Blumenkrantz M.J. Nutrition. - In: Handbook of Dialysis. Second Edition, 1994; 374-400.Blumenkrantz M.J. Nutrition. - In: Handbook of Dialysis. Second Edition, 1994; 374-400.Blumenkrantz M.J., Kopple J.D., Moran J.K., Coburn J.W. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1982; 21; 849-861.Blumenkrantz M.J., Kopple J.D., Moran J.K., Coburn J.W. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1982; 21; 849-861.Blumenkrantz M.J., Kopple J.D., Moran J.K. et al. Nitrogen and urea metabolizm during continuous ambulatory peritoneal dialysis. Kidney Int. 20; 78-82.Blumenkrantz M.J., Kopple J.D., Moran J.K. et al. Nitrogen and urea metabolizm during continuous ambulatory peritoneal dialysis. Kidney Int. 20; 78-82.Boeschoten E.W., Zuyderhoudt F.M.J., Krediet R.T., Arsz L. Changes in weight and lipid concentrations during CAPD treatment. Periton. Dial. Int. 1988; Vol.8; 1:19-24.Boeschoten E.W., Zuyderhoudt F.M.J., Krediet R.T., Arsz L. Changes in weight and lipid concentrations during CAPD treatment. Periton. Dial. Int. 1988; Vol.8; 1:19-24.Boeschoten E.W., Schrijver J., Krediet R.T., Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol. Dial. Transplant. 1988; 2: 187-193.Boeschoten E.W., Schrijver J., Krediet R.T., Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol. Dial. Transplant. 1988; 2: 187-193.Bouma S., Dwyer J.T. Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J. Am. Diet Assoc. 1984; 84: 194-197.Bouma S., Dwyer J.T. Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J. Am. Diet Assoc. 1984; 84: 194-197.Breckenridge W.C., Roncary D.A.K., Khanna R., Oreopoulos D.G. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis. 1982; 45: 249-258.Breckenridge W.C., Roncary D.A.K., Khanna R., Oreopoulos D.G. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis. 1982; 45: 249-258.DeSantos N.G., Capodicasa G., Senatore T. et al. Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis CAPD.lnt. J. Arif. Org. 1979; 2: 119-124.DeSantos N.G., Capodicasa G., Senatore T. et al. Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis CAPD.lnt. J. Arif. Org. 1979; 2: 119-124.Dulaney J.T., Hatch F.E. Peritoneal dialysis and loss of proteins: a review. Kidney Int. 1984; 26: 253-262.Dulaney J.T., Hatch F.E. Peritoneal dialysis and loss of proteins: a review. Kidney Int. 1984; 26: 253-262.European Dialysis and Transplant Association - European Renal Association, EDTA/ERA Registry Report, Demography of Dialysis and Transplantation in Europe, 1984; Nephrol. Dial. Transplant. 1986; 1: 1-8.European Dialysis and Transplant Association - European Renal Association, EDTA/ERA Registry Report, Demography of Dialysis and Transplantation in Europe, 1984; Nephrol. Dial. Transplant. 1986; 1: 1-8.Gokal R., Ramos J.M., McGurk J.G., Ward M.K., Kerr D.N.S. Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. In: Gahl G.M., Kessel M., Nolph K.D. eds. Advances in Peritoneal dialysis. -Amsterdam, Excerpta Medica. 1981; 430-433.Gokal R., Ramos J.M., McGurk J.G., Ward M.K., Kerr D.N.S. Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. In: Gahl G.M., Kessel M., Nolph K.D. eds. Advances in Peritoneal dialysis. -Amsterdam, Excerpta Medica. 1981; 430-433.Grutzmacher P., Marz W., Peschke B. et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron. 1988; Vol.50; 1: 103-111.Grutzmacher P., Marz W., Peschke B. et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron. 1988; Vol.50; 1: 103-111.Hanning R., Baife J.W., ZIotkins S. Effectiveness and nutritional consequences of amino acids vs glucose-based dialysis solutions in infants and children receiving CAPD. Am. J. Clin. Nutr. 1987; 46: 22-30.Hanning R., Baife J.W., ZIotkins S. Effectiveness and nutritional consequences of amino acids vs glucose-based dialysis solutions in infants and children receiving CAPD. Am. J. Clin. Nutr. 1987; 46: 22-30.Harty J., Gokal R. Nutritional status in peritoneal dialysis. J. Renal Nutr. 1995; Vol. 5; 1: 2-10.Harty J., Gokal R. Nutritional status in peritoneal dialysis. J. Renal Nutr. 1995; Vol. 5; 1: 2-10.Heide В., Pierratos A., Khanna R., Petit J., Ogilvie R. et al. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis CAPD. Perit. Dial. Bull. 1983; 3: 138-141.Heide В., Pierratos A., Khanna R., Petit J., Ogilvie R. et al. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis CAPD. Perit. Dial. Bull. 1983; 3: 138-141.Henderson I.S., Leung A.C.T., Shenkin A. Vitamin status in continuous ambulatory peritoneal dialysis. Perit. Dial. Bull. 1984; 4: 143-145.Henderson I.S., Leung A.C.T., Shenkin A. Vitamin status in continuous ambulatory peritoneal dialysis. Perit. Dial. Bull. 1984; 4: 143-145.Hopkins P.M., Williams R.R. A survey of suggested coronary risk factors. Atherosclerosis. 1981; Vol.40; 1; 1-52.Hopkins P.M., Williams R.R. A survey of suggested coronary risk factors. Atherosclerosis. 1981; Vol.40; 1; 1-52.Kaysen G.A. Hyperlipidemia of chronic renal failure. Blood Purific. 1994; Vol.12; 1: 60-67.Kaysen G.A. Hyperlipidemia of chronic renal failure. Blood Purific. 1994; Vol.12; 1: 60-67.Kopple J.D., Blumenkrantz M.J., Jones M.R. et al. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am. J. Clin. Nutr. 1982; 36: 395-402.Kopple J.D., Blumenkrantz M.J., Jones M.R. et al. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am. J. Clin. Nutr. 1982; 36: 395-402.Kopple J.D., Blumenkrantz M.J. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1983; 24 suppl. 16: S295-S302.Kopple J.D., Blumenkrantz M.J. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1983; 24 suppl. 16: S295-S302.Krediet R.T., Zuyderhondt F.M.J., Boeschoten E.W., Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis. Nephron. 1986; 42: 133-140.Krediet R.T., Zuyderhondt F.M.J., Boeschoten E.W., Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis. Nephron. 1986; 42: 133-140.Kurtz S.B., Wong V.H., Anderson C.F. et al. Continuous ambulatory peritoneal dialysis. Three years experience at the Mayo Clinic. Mayo Clin. Proc. 1983; 58: 633-639.Kurtz S.B., Wong V.H., Anderson C.F. et al. Continuous ambulatory peritoneal dialysis. Three years experience at the Mayo Clinic. Mayo Clin. Proc. 1983; 58: 633-639.Lacour В., Drueke T. Lipid metabolism and endocrine disturbances in uremia. Textbook of nephrology. Ed. Massery S.G., Glassock R.J. 3-rd Ed. 1995; Vol.2; 2025.Lacour В., Drueke T. Lipid metabolism and endocrine disturbances in uremia. Textbook of nephrology. Ed. Massery S.G., Glassock R.J. 3-rd Ed. 1995; Vol.2; 2025.Lindholm В., Bergstrom J. Nutritional requierments of peritoneal dialysis patients. Textbook of peritoneal dialysis. Ed. Gokal R., Nolph K.D. 1-st Ed. 1994; 443-472.Lindholm В., Bergstrom J. Nutritional requierments of peritoneal dialysis patients. Textbook of peritoneal dialysis. Ed. Gokal R., Nolph K.D. 1-st Ed. 1994; 443-472.Lindhotm В., Bergstrom J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis CAPD. Clin. Nephrol. 1988; 30: suppl. 1. 859-S63.Lindhotm В., Bergstrom J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis CAPD. Clin. Nephrol. 1988; 30: suppl. 1. 859-S63.Mistry C.D., Gokal R. New osmotic agents for peritoneal dialysis: where we are and where we»re going. Semin. Dial. 1990; 4: 9-12.Mistry C.D., Gokal R. New osmotic agents for peritoneal dialysis: where we are and where we»re going. Semin. Dial. 1990; 4: 9-12.Mitch W.E., Klahr S. Handbook of nutrition and the kidney.3-d Ed. NY. 1998; 384.Mitch W.E., Klahr S. Handbook of nutrition and the kidney.3-d Ed. NY. 1998; 384.Nolph K.D., Sorkin M.N., Rubin J. et al. Continuous ambulatory peritoneal dialysis. Three-year experience at one center. Ann. Intern. Med. 1980; 92: 609-613.Nolph K.D., Sorkin M.N., Rubin J. et al. Continuous ambulatory peritoneal dialysis. Three-year experience at one center. Ann. Intern. Med. 1980; 92: 609-613.Oren A., Wu G., Anderson G.H. et al. Effective use of amino acid dialysate over four weeks in CAPD patients. Perit. Dial. Bull. 1983; 3: 66-73.Oren A., Wu G., Anderson G.H. et al. Effective use of amino acid dialysate over four weeks in CAPD patients. Perit. Dial. Bull. 1983; 3: 66-73.Oreopoulos D.G., Khanna R., McCready W. et al. Continuous ambulatory peritoneal dialysis in Canada. Dial. Transplant. 1980; 9: 224-226.Oreopoulos D.G., Khanna R., McCready W. et al. Continuous ambulatory peritoneal dialysis in Canada. Dial. Transplant. 1980; 9: 224-226.Schilling H., Wu G., Petit J. et al. Nutritional status of patients on long-term CAPD. Perit. Dial. Bull. 1985; 5: 12-18.Schilling H., Wu G., Petit J. et al. Nutritional status of patients on long-term CAPD. Perit. Dial. Bull. 1985; 5: 12-18.Schreiber M.J. Clinical tools for assessing the adequacy of peritoneal dialysis /nephrology update/. Cleveland Clinic Foundation. 1990; 1-4.Schreiber M.J. Clinical tools for assessing the adequacy of peritoneal dialysis /nephrology update/. Cleveland Clinic Foundation. 1990; 1-4.Spiegel D.M., Anderson M., Campbell U. et al. Serum albumin: A marker for morbidity in peritoneal dialysis patients. Am. J. Kidney Dis. 1993; 21: 26-30.Spiegel D.M., Anderson M., Campbell U. et al. Serum albumin: A marker for morbidity in peritoneal dialysis patients. Am. J. Kidney Dis. 1993; 21: 26-30.Struiik D.G., Krediet R.T., Koomen G.C.M. et al. The effect of serum albumin at the start of CAPD on patient survival. Perit. Dial. Int. 1994; 14: 121-126.Struiik D.G., Krediet R.T., Koomen G.C.M. et al. The effect of serum albumin at the start of CAPD on patient survival. Perit. Dial. Int. 1994; 14: 121-126.Teehan В.P., Schleifer C.R., Brow J.M. et al. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv. Pent. Dial. 1991; 6: 181-185.Teehan В.P., Schleifer C.R., Brow J.M. et al. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv. Pent. Dial. 1991; 6: 181-185.Traneous A., Heimburger O., Lindholm B. et al. Six years experience of CAPD at one centre: a survey of major findings. Periton. Dial. Int. 1988; 8: 31-41.Traneous A., Heimburger O., Lindholm B. et al. Six years experience of CAPD at one centre: a survey of major findings. Periton. Dial. Int. 1988; 8: 31-41.Tsukamoto Y., Wakabaywshi Y., Okubo M. et al. Abnormal lipid profiles at various stages of uremia. Nephrol. Dial. Transplant. 1989; Vol.4; Suppl. 3. 142-145.Tsukamoto Y., Wakabaywshi Y., Okubo M. et al. Abnormal lipid profiles at various stages of uremia. Nephrol. Dial. Transplant. 1989; Vol.4; Suppl. 3. 142-145.Vennegoor M. ed. Nutrition for patients with renal failure. EDNTA -ERCA Publication. 1986; 184.Vennegoor M. ed. Nutrition for patients with renal failure. EDNTA -ERCA Publication. 1986; 184.Verger С., Larpent L., Dumontent M. Prognostic value of peritoneal equilibration curves EC in CAPD patients. In: Maher J.F., Winchester J.F. eds, Frontiers in peritoneal dialysis Field Rich and Assoc., Inc., NY. 1986; 88-93.Verger С., Larpent L., Dumontent M. Prognostic value of peritoneal equilibration curves EC in CAPD patients. In: Maher J.F., Winchester J.F. eds, Frontiers in peritoneal dialysis Field Rich and Assoc., Inc., NY. 1986; 88-93.Williams P., Kay R., Harrison J. et al. Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. Perit. Dial. Bull. 1981; 1: 82-87.Williams P., Kay R., Harrison J. et al. Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. Perit. Dial. Bull. 1981; 1: 82-87.Young G.A., Brownjohn A.M., Parsons F.M. Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephrol. 1987; 45: 196-201.Young G.A., Brownjohn A.M., Parsons F.M. Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephrol. 1987; 45: 196-201.Young Q.A., Kopple J.D., Lindholm B. et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am. J. Kidney Dis. 1991; 17: 462-471.Young Q.A., Kopple J.D., Lindholm B. et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am. J. Kidney Dis. 1991; 17: 462-471.

The authors declare that there are no conflicts of interest present.